Liège-based pharmaceutical company Mithra, in partnership with Mayne Pharma Group, has announced the commercial launch of NextCellis, the first oral contraceptive based on a new estrogen, in Australia.
****** ********** ************* *** ** ******* ********** ** ********** ** ******* ********** ***** ************** * * * *********** **** ** **** ***** ****** ** ********** *** ** ***** ** ********** ** *********** ** ******* ********** * * **** ** **** ****** ****** ************** ** ****** ****** * * ***** ********** *****
******** *** ** ********** ***** ******* *** ** ***** **** * * ******* ** ********** ** ******* ** ******* ** ******* * ** ******** **** ** *********** ***********
** ******* *** ********** ********** *** ** ******* ****** **** *** ************** ***** ********* ************** *** * * ********* *** ************** ***** ********* ******* ** * * ***** ************** ** **** ********** **** ***** **** * ** **** ** ****** ************** * ***** ********
******************************
**** *** ******* *** ** ******* ** ******** ** ** ********** ******* ** ** ******* **************
“Certified food fanatic. Extreme internet guru. Gamer. Evil beeraholic. Zombie ninja. Problem solver. Unapologetic alcohol lover.”
More Stories
FBI Director Sees TikTok as US “National Security Problem”
After adopting a text threatening to ban TikTok in the US: Can the social network be banned in France?
Australia's Venice wins the Golden Lion Award for Best Pavilion